Table 5.

Grouping by APASL treatment guidelines (among HBsAg positive individuals with HBV DNA, ALT, and HBeAg)

	All Asian Countries (n=1,113)	Korea (n=125)	Gyeonggi Province (n=53)	Non- Gyeonggi Province (n=56)	Malaysia (n=34)	China (n=927)	Fujian Province (n=641)	Non-Fujian Province (n=206)
HBV DNA ≥ 100,000 and ALT >2xULN	124 (11.2)	15 (12.0)	6 (11.3)	7 (12.5)	2 (5.9)	105 (11.3)	75 (11.7)	16 (7.8)
HBeAg- and VL between 10,000 - 99,999 and ALT >2xULN	88 (7.9)	11 (8.8)	8 (15.1)	2 (3.6)	7 (20.6)	65 (7.0)	43 (6.7)	13 (6.3)
HBV DNA <10,000	654 (58.9)	823 (65.6)	32 (60.4)	40 (71.4)	19 (55.9)	541 (76.1)	367 (57.3)	128 (62.1)